Japan's nationwide unemployment rate stood at 2.5 percent in January, unchanged from the previous month, data from the ...

The number of children born in Japan in 2024 fell from a year earlier to 720,988, marking the ninth consecutive year of ...

Japan's population decline is accelerating. The number of deaths rose by 1.8 percent to 1,618,684, while the natural decrease ...

Sanofi's Sarclisa (isatuximab) has gained approval from Japan’s Ministry of Health, Labour and Welfare for use in conjunction ...

Japan's AMR response from 2013 to 2025 focuses on surveillance, antimicrobial stewardship, infection prevention, and research ...

Japan's Ministry of Health, Labor and Welfare (MHLW) has granted manufacturing and marketing approval for Andembry ...

The Japanese Ministry of Health, Labor and Welfare (MHLW) in Japan has approved Sarclisa (isatuximab), in combination with ...

Paris: Sanofi has announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Sarclisa, in ...

CSL Behring KK has gained approval from Japan's MHLW to manufacture and market subcutaneous injection 200mg Andembry pens.

Japan's population decline is accelerating. The number of deaths rose by 1.8 percent to 1,618,684, while the natural decrease ...

Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma Approval offers access to new treatment options for newly diagnosed MM patients Approval based on positive results from ...